Orcosa Inc.

Ewing, NJ · Founded 2020 · CIK 0001852165 · Medtech

next-generation drug delivery technology platform

orcosa.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$49M
3 Form D · Jan 2025
21 months since last filing
Contracts
—
No federal contracts on record
Patents
40
2 granted · 38 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$37,925,000
Private capital raisedForm D · SEC$3,529,800
Private capital raisedForm D · SEC$7,275,000
Form D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1426DIASCOPIC, LLC——
1427BUY TIME MEDICAL INC——
1428Vifant LLC——
1429Orcosa Inc.—$49M
1430BH2 Innovations Inc.—$275K
1431EKO Devices, Inc.——
1432Pulmokine, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Vincent MiletoDirector · Executive Officer
  • Robert PollaroDirector · Executive Officer
  • Bryan RidallDirector · Executive Officer
  • Mark RidallDirector · Executive Officer

Patents

USPTO · 2 granted of 40
  • Packaging For Rapidly Infusing Compositionapplication
  • Packaging For Rapidly Infusing Compositiongranted
  • Methods Of Treating Autoimmune Or Inflammatory Conditions With Cannabidiol Or Its Derivatives/analogsapplication
  • Cannabinoids In The Treatment Of Autism Spectrum Disorderapplication
  • Rapidly Infusing Compositions For Oral Mucosal Delivery And Methodsapplication
  • Rapidly Infusing Compositions With Supplements And Treatment Methodsapplication
  • Use Of Cannabinoids In The Treatment Of Tourette Syndrome And Tic Disordersapplication
  • Improved Use Of Cannabinoids In The Treatment Of Epilepsyapplication
  • Improved Use Of Cannabinoids In The Treatment Of Alzheimer's Diseaseapplication
  • Rapidly Infusing Cannabinoid Compositions, Processes Of Manufacture, And Methods Of Useapplication
  • Rapidly Infusing Compositions With Methotrexate And Treatment Methodsapplication
  • RAPIDLY DISINTERGRATING COMPOSITIONS AND METHODS (Nicotine)application

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.